Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors

The majority of patients with advanced ovarian germ cell cancer are treated by cisplatin-based chemotherapy. Despite adequate first-line treatment, nearly one third of patients relapse and almost half develop cisplatin-resistant disease, which is often fatal. The treatment of cisplatin-resistant dis...

Descripción completa

Detalles Bibliográficos
Autores principales: De Giorgi, Ugo, Casadei, Chiara, Bergamini, Alice, Attademo, Laura, Cormio, Gennaro, Lorusso, Domenica, Pignata, Sandro, Mangili, Giorgia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826947/
https://www.ncbi.nlm.nih.gov/pubmed/31627378
http://dx.doi.org/10.3390/cancers11101584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826947/
https://www.ncbi.nlm.nih.gov/pubmed/31627378
http://dx.doi.org/10.3390/cancers11101584

Ejemplares similares